Six-minute walk test in Chagas cardiomyopathy

International Journal of Cardiology

Volumn 125, Issue 1, 2008, Pages 139-141

  Sousa, Lidiane ^a,b,c   Botoni, Fernando Antônio ^c   Britto, Raquel R ^a   Rocha, Manoel Otávio da Costa ^c   Teixeira Jr , Antonio Lúcio ^c   Teixeira, Mauro Martins ^c   Reis, Adelina M ^c   Oliveira, Bráulio Muzzi R ^c   Ribeiro, Antonio L ^c  

^a Pesquisa em Desempenho Cardiorrespiratório   (Brazil)

^b CENTRO UNIVERSITÁRIO NEWTON PAIVA   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Chagas disease; Inflammation; Six minute walk test

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; ARTICLE; CHAGAS DISEASE; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; HEART EJECTION FRACTION; HEMODYNAMIC PARAMETERS; HUMAN; HUMORAL IMMUNITY; MALE; PRIORITY JOURNAL; WALKING;

CHAGAS CARDIOMYOPATHY; CHEMOKINE CCL2; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PILOT PROJECTS; STROKE VOLUME; TIME FACTORS;

EID: 39749110065     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.01.034     Document Type: Article

References (14)

1. WHO Expert Committee on the control of Chagas disease. Control of Chagas Disease (1991) 1-95
2. Ribeiro A.L., Reis A.M., Barros M.V., et al. Brain natriuretic peptide in the diagnosis of systolic left ventricular dysfunction in Chagas disease. Lancet 360 (2002) 461-462
3. Talvani A., Rocha M.O.C., Barcelos L.S., Gomes Y.M., Ribeiro A.L.P., and Teixeira M.M. Elevated concentrations of CCL-2 and tumor necrosis factor-∝ in chagasic cardiomyopathy. Clin Infect Dis 38 (2004) 943-950
4. Steele B. Timed walking tests of exercise capacity in chronic cardiopulmonary illness. J Cardiopulm Rehabil 16 (1996) 25-33
5. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166 (2002) 111-117
6. Sahn D.J., De Maria A., Kisslo J., and Weiman A. Recommendations regarding quantification in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58 (1978) 1072-1083
7. Zugck C., Kruger C., Durr S., et al. Is the 6-minute walk test a reliable substitute for peak oxygen uptake in patients with dilated cardiomyopathy?. Eur Heart J 21 (2000) 540-549
8. Cahalin L.P., Mathier M.A., Semigran M.J., Dec W., and DiSalvo T.G. The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest 110 (1996) 325-332
9. Enright P.L., McBurnie M.A., Bittner V., et al. The 6-min walk test: a quick measure of functional status in elderly adults. Chest 123 (2003) 387-398
10. Krum H., Sackner-Bernstein J.D., Goldsmith R.L., et al. Double blind placebo controlled study of the long term efficacy of carvedilol in patients with severe chronic heart failure. Circulation 92 (1995) 1499-1506
11. Reid M.B., Lannergren J., and Westerblad H. Respiratory and limb muscle weakness induced by tumor necrosis factor-∝. Am J Respir Crit Care Med 166 (2002) 479-484
12. Kuster G.M., Tanner H., Printzen G., Suter T.M., Mobacsi O., and Hess OM. B-type natriuretic peptide for diagnosis and treatment of congestive heart failure. Swiss Med Wkly 132 (2003) 623-628
13. Carrasco H.A., Parada H., Guerrero L., Duque M., Duran D., and Molina C. Prognostic implications of clinical, electrocardiographic and hemodynamic findings in chronic Chagas' disease. Int J Cardiol 43 (1994) 27-38
14. Olsson L.G., Swedberg K., Clark A.L., Witte K.K., and Cleland J.G.F. Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review. Eur Heart J 26 (2005) 778-793